Dexcom G6® Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries with Diabetes in Early 2019
CMS approves coverage for Dexcom G6 CGM, the only CGM system
“The Dexcom G6 is a game-changer for people with diabetes, and we are
thrilled to provide this innovative technology to the many Americans
with diabetes who rely on Medicare,” said
The new Dexcom G6 boasts a number of features that make it a very powerful diabetes management tool.
- Zero fingersticks – No fingersticks needed for calibration or diabetes treatment decisions
- One-touch applicator – Redesigned one-touch applicator that is virtually painless
- Low-profile wearable – New transmitter with a 28 percent lower profile for comfortable wear
- Mobile compatibility – Compatibility with smart device apps to display and share glucose information with up to five people
- Alerts and alarms – Customizable alerts and alarms to proactively warn users of pending dangerous high and low blood sugar levels
Who is covered?
According to CMS, therapeutic CGM may be covered by
- The beneficiary has diabetes mellitus; and,
- The beneficiary has been using a home blood glucose monitor (BGM) and performing frequent (four or more times a day) BGM testing; and,
- The beneficiary is insulin-treated with multiple daily injections (MDI) of insulin or a continuous subcutaneous insulin infusion (CSII) pump; and,
- The beneficiary’s insulin treatment regimen requires frequent adjustment by the beneficiary on the basis of therapeutic CGM testing results; and,
- In six (6) months prior to ordering the CGM, the beneficiary had an in-person visit with the treating practitioner to evaluate their diabetes control and determine that the above criteria are met; and,
- Every six (6) months following the initial prescription of the CGM, the beneficiary has an in-person visit with the treating practitioner to assess adherence to their CGM regimen and diabetes treatment plan.
How to get the Dexcom G6? It’s easy.
New customers of
Dexcomcan get started today with Dexcom G5 Mobile by going to http://www.dexcom.com/medicare-coverage.
Once G6 is available,
Dexcomwill be reaching out to current MedicareG5 customers when their transmitter is eligible to be replaced. Dexcomwill also discuss the G6 and the Medicarebeneficiary’s eligibility during routine monthly contact.
CGM devices are considered one of the most significant breakthroughs in
diabetes management in the past 40 years1., and
1. Clarke SF and Foster JR. A history of blood glucose meters
and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci.
2. 2014 National Diabetes Statistics Report.
3. Hyperglycemia (High blood glucose).
4. Hypoglycemia (Low blood glucose).
Steve Pacelli, 858-200-0200
James McIntosh, 619-884-2118